Thiopurine metabolite testing in inflammatory bowel disease.
about
Weight and Body Composition Compartments do Not Predict Therapeutic Thiopurine Metabolite Levels in Inflammatory Bowel Disease.Examining maintenance care following infliximab salvage therapy for acute severe ulcerative colitis.Medication non-adherence in adult patients affected by inflammatory bowel disease: a critical review and update of the determining factors, consequences and possible interventions.The glutathione transferase Mu null genotype leads to lower 6-MMPR levels in patients treated with azathioprine but not with mercaptopurine.Allopurinol in combination with thiopurine induces mucosal healing and improves clinical and metabolic outcomes in IBD.
P2860
Thiopurine metabolite testing in inflammatory bowel disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Thiopurine metabolite testing in inflammatory bowel disease.
@en
type
label
Thiopurine metabolite testing in inflammatory bowel disease.
@en
prefLabel
Thiopurine metabolite testing in inflammatory bowel disease.
@en
P2093
P2860
P356
P1476
Thiopurine metabolite testing in inflammatory bowel disease.
@en
P2093
Georgina Cunningham
Julien Schulberg
Michael A Kamm
Philip Marsh
Sally Bell
Steven Brown
William Connell
P2860
P304
P356
10.1111/JGH.13210
P577
2015-10-29T00:00:00Z